Stemline Therapeutics Reports Second Quarter 2016 Financial Results and Highlights Recent Clinical Progress
NEW YORK, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today reported financial results for the quarter ended June 30, 2016. Clinical highlights and milestones include: SL-401 in blastic plasmacytoid dendritic cell neoplasm ( …